You are here

Abcuro

Abcuro raises $200m to take muscle disease drug to market

Pharmaphorum

Wed, 02/12/25 - 09:34 am

inclusion body myositis

Biopharma Investments Strong in the First Week of 2021

BioSpace

Thu, 01/7/21 - 11:07 pm

Scorpion Therapeutics

Werewolf Therapeutics

Kira Pharmaceuticals

Carisma Therapeutics

Endeavor BioMedicines